Nutritional factors and osteoporosis prevention

Nutritional Factors and Osteoporosis Prevention

Volumn , Issue , 2010, Pages 1-128

  Yamaguchi, Masayoshi ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892822538     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Book

References (239)

1. Cooper, C. & Melton, J. III. (1995). Epidemiology of osteoporosis. Trends Endocrinol. Metab., 3, 224-229.
2. Riggs, B. L., Jowsey, J., Kelly, P. J., Jones, J. D. & Maher, F. T. (1969). Effect of sex hormones on bone in primary osteoporosis. J. Clin. Invest., 48, 1065-1072.
3. Bonjour, J. P., Schurch, M. A. & Rizzori, R. (1996). Nutritional aspects of hip fracture. Bone, 18, 1395-1445.
4. Yamaguchi, M. (2002). Isoflavone and bone metabolism: Its cellular mechanism and preventive role in bone loss. J. Health Sci., 48, 209-222.
5. Yamaguchi, M. (2006). Regulatory mechanism of food factors in bone metabolism and prevention of osteoporosis. Yakugaku Zasshi, 126, 1117-1137.
6. Yamaguchi, M. (2007). Role of zinc in bone metabolism and preventive effect on bone disorder. Biomed. Res. Trace Elements, 18, 346-366.
7. Yamaguchi, M. (2008). β-Cryptoxanthin and bone metabolism: The preventive role of osteoporosis. J Health Sci., 54, 356-369.
8. Parfitt, A. M. (1990). Bone-forming cells in clinical conditions. In: Hall, B. K., editor. Bone Volume 1. The Osteoblast and Osteocyte. Boca Raton, FL: Telford Press and CRC Press, p.351-429.
9. Baron, R., Vignery, A. & Horowitz, M. (1984). Lymphocytes, macrophages and the regulation of bone remodeling. Bone Miner. Res., 2, 175-243.
10. Canalis, E., McCarthy, T. & Centrella, M. (1988). Growth factors and the regulation of bone remodeling. J. Clin. Invest., 81, 277-281.
11. Prasad, A. S., Halsted, J. A. & Nadimi, M. (1961). Syndrome of iron deficiency anemia, hepatosplenomegaly, hupogonadism, dwarfism and geophagia. Am. J Med, 31, 532-546.
12. Burch, R. E., Hahn, H. K. & Sullivan, J. F. (1975). Newer aspects of the roles of zinc, manganese, and copper in human nutrition. Clin. Chem., 21, 501-520.
13. Parisi, A. F. & Vallee, B. L. (1969). Zinc metalloenzyme: Characteristic and significance in biology and medicine. Am. J. Clin. Nutr., 22, 1222-1230.
14. Hsieh, H. S. & Navia, J. M. (1980). Zinc deficiency and bone formation in guinea pig alveolar implants. J. Nutr., 110, 1581-1588.
15. Oner, G., Bhaumick, B. & Bala, R. M. (1984). Effect of zinc deficiency on serum somatomedin levels and skeletal growth in young rats. Endocrinology 114, 1860-1863.
16. Hurley, L.S. (1981). Tetratogenic aspects of manganese, zinc, and copper nutrition. Physiological Reviews, 61, 249-295.
17. da Cunha Ferreira, R. M., Marguiegui, I. M. & Elizaga, I. V. (1989). Tetratogenicity of zinc deficiency in the rat: Study of the fetal skeleton. Tetratology, 39, 181-194.
18. Leek, J. C., Vogler, J. B., Gershwin, M. E., Golub, M. S., Hurley, L. S. & Hendrickx, A. G. (1984). Studies of marginal zinc deprivation in rhesus monkeys. V. Fetal and infant skeletal defects. Am. J. Clin. Nutr., 40, 1203-1212.
19. Ronaghy, H. A., Reinhold, J. G., Mahloudji, M., Ghavami, P., Spirey Fox, M. R. & Halstead, J. A. (1984). Zinc supplementation of malnourished schoolboys in Iran: Increased growth and other effects. Am. J. Clin. Nutr., 40, 1203-1212.
20. Herzberg, M., Foldes, J., Steinberg, R. & Menczel, J. (1990). Zinc excretion in osteoporotic women. J. Bone Mineral. Res., 5, 251-257.
21. Haumont, S. (1961). Distribution of zinc in bone tissues. J. Histochem. Cytochem., 9, 141.
22. Hurley, L. S. & Shyy-Hwa, T. (1972). Alleviation of tetratogenic effects of zinc deficiency by simultaneous lack of calcium. Am. J. Phys., 222, 322-325.
23. Masters, D. G., Keen, C. L., Lonnerdal, B. & Hurley, L. S. (1986). Release of zinc from maternal tissues during zinc deficiency or simultaneous zinc and calcium deficiency in the pregnant rat. J. Nutr., 116, 2148-2154.
24. Murray, E. J. & Messer, H. H. (1981). Turnover of bone zinc during normal and accelerated bone loss in rats. J. Nutr., 111, 1641-1647.
25. Sherman, S. S., Smith, J. C., Tobin, J. D. & Soares, J. H. (1989). Ovariectomy, dietary zinc, and bone metabolism in retired breeder rats. Am. J. Clin. Nutr., 49, 1184-1191.
26. Aitken, J. M. (1976). Factors affecting the distribution of zinc in the human skeleton. Calcif. Tissue Res., 20, 23-30.
27. Sauer, G. R. & Wuthier, R. E. (1990). Distribution of zinc in the avian growth plate. J. Bone Mineral. Res., 5 (Suppl. 2), S162.
28. Lappalainer, R., Knuuttila, M., Lammi, S. & Alhava, E. M. (1983). Fluoride content related to the elemental composition, mineral density and strength of bone in healthy and chronically diseased persons. J. Chronic Disease, 36, 707-713.
29. Reginster, J. Y., Strause, L. G., Saltman, O. & Franchimont, P. (1988). Trace elements and postmenopausal osteoporosis: A preliminary study of decreased serum manganese. Med. Sci. Res., 16, 337-338.
30. Majeska, R. J. & Wuthier, R. E. (1975). Studies on matrix vesicles Isolated from chick epiphyseal cartilage. Association of pyrophosphatase and ATPase activities with alkaline phosphatase. Biochim. Biophys. Acta, 391, 51-60.
31. Lian, J. B., Stein, G. S., Cannalis, E., Roky, P. G., & Boskey, A. L. (1999). Bone formation: Osteoblast lineage cells, growth factor, matrix protein, and the mineralization process. In: Favus MJ (Ed), Primer on the Metabolic Bone Disease and Disorders of Mineral Metabolism (4th edition), pp 14-29. New York, Lippincott Williams & Wilkins Press
32. Yamaguchi, M. & Takahashi, K. (1984). Role of zinc as an acivator of bone metabolism in weanling rats. Jpn. J. Bone Metab., 2, 186-191.
33. Yamaguchi, M., Inamoto, K. & Suketa, Y. (1986). Effect of essential trace metals on bone metabolism in weanling rats: Comparison with zinc and other metals̀actions. Res. Exp. Med., 186, 337-342.
34. Yamaguchi, M. & Uchiyama, M. (1987). Preventive effect of zinc for toxic actions of germanium and selenium on bone metabolism in weanling rats. Res. Exp. Med., 187, 395-400.
35. Lai, Y. L. & Yamaguchi, M. (2005). Effects of copper on bone component in the femoral tissues of rats: Anabolic effect of zinc is weakened by copper. Biol. Pharm. Bull., 28, 2296-2301.
36. Yamaguchi, M. & Sakashita, T. (1986). Enhancement of vitamin D3 effect on bone metabolism in weanling rats orally administered zinc sulphate. Acta Endocrinol., 111, 285-288.
37. Yamaguchi, M. & Yamaguchi, R. (1986). Action of zinc on bone metabolism in rats. Increases in alkaline phosphatase activity and DNA content. Biochem. Pharmacol., 35, 773-777.
38. Yamaguchi, M. & Inamoto, K. (1986). Differential effects of calcium-regulating hormones on bone metabolismin weanling rats orally administered zinc sulfate. Metabolism, 35, 1044-1047.
39. McDonnell, D. P., Mongelsdorf, D. J., Pike, J. W., Haussler, M. R. & O'Malley, B. W. (1987). Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. Science, 235, 1214-1217.
40. Yamaguchi, M., Osishi, H. & Suketa, Y. (1987). Stimulatory effect of zinc on bone formation in tissue culture. Biochem. Pharmacol., 36, 4007-4012.
41. Yamaguchi, M., Oishi, H. & Suketa, Y. (1988). Zinc stimulation of bone protein synthesis in tissue culture. Activation of aminoacyl-tRNA synthetase. Biochem. Pharmacol., 37, 4075-4080.
42. Yamaguchi, M. & Matsui, R. (1989). Effect of dipicolinate, a chelator of zinc, on bone protein synthesis in tissue culture. The essential role of zinc. Biochem. Pharmacol., 38, 4485-4489.
43. Shimokawa, N. & Yamaguchi, M. (1992). Characterization of bone protein components with polyacrylamide gel electrophoresis: Effects of zinc and hormones in tissue culture. Mol. Cell. Biochem., 117, 153-158.
44. Yamaguchi, M. & Oishi, H. (1989). Effect of 1,25-dihydroxyvitamin D3 on bone metabolism in tissue culture. Enhancement of this steroid effect by zinc. Biochem. Pharmacol., 38, 3453-3459.
45. Yamaguchi, M. & Kitajima, T. (1991). Effect of estrogen on bone metabolism in tissue culture: Enhancement of the steroid effect by zinc. Res. Exp. Med., 191, 145-154.
46. Hashizume, M. & Yamaguchi, M. (1993). Stimulatory effect of β-alanyl-L-histidinato zinc on cell proliferation is dependent on protein synthesis in osteoblastic MC3T3-E1 cells. Mol. Cell. Biochem., 122, 59-64.
47. Hashizume, M. & Yamaguchi, M. (1994). Effect of β-alanyl-L-histidinato zinc on differentiation of osteoblastic MC3T3-E1 cells: Increases in alkaline phosphatase activity and protein concentration. Mol. Cell. Biochem., 131, 19-24.
48. Yamaguchi, M. & Hashizume, M. (1994). Effect of β-alanyl-L-histidinato zinc on proein components in osteoblastic MC3T3-E1 cells: Increases in osteocalcin, insulin-like growth factor-I and transforming growth factor-β. Mol. Cell. Biochem., 136, 163-169.
49. Matsui, T. & Yamaguchi, M. (1995). Zinc modulation of insulin-like growth factor's effect in osteoblastic MC3T3-E1 cells. Peptides, 16, 1063-1068.
50. Yamaguchi, M. & Fukagawa, M. (2005). Role of zinc in regulation of protein tyrosine phosphatase activity in osteoblastic MC3T3-E1 cells: Zinc modulation of insulin-like growth factor-I's effect. Calcif. Tissue Int., 76, 32-38.
51. Yamaguchi, M., Kishi, S. & Hashizume, M. (1994). Effect of zinc-chelating dipeptides on osteoblastic MC3T3-E1 cells: Activation of aminoacyl-tRNA synthetase. Peptides, 15, 1367-1371.
52. Yamaguchi, M. & Matsui, T. (1996). Stimulatory effect of zinc-chelating dipeptide on deoxyribonucleic acid synthesis in osteoblastic MC3T3-E1 cells. Peptide, 17, 1207-1211.
53. Yamaguchi, M., Goto, M., Uchiyama, S. & Nakagawa, T. (2008). Effect of zinc on gene expression in osteoblastic MC3T3-E1 cells: enhancement of Runx2, OPG, and regucalcin mRNA expressions. Mol. Cell. Biochem., 312, 157-166.
54. Yamaguchi, M., Segawa, Y., Shimokawa, N., Tsuzuike, N. & Tagashira, E. (1992). Inhibitory effect of β-alanyl-L-histidinato zinc on bone resorption in tissue culture. Pharmacology, 45, 292-300.
55. Yamaguchi, M. & Hashizume, M. (1994). Effect of parathyroid hormone and interleukin-1α in osteoblastic MC3T3-E1 cells: Interaction with β-alanyl-L-histidinato zinc. Peptides, 15, 633-636.
56. Kishi, S. & Yamaguchi, M. (1994). Inhibitory effect of zinc compounds on osteoclast-like cell formation in mouse marrow cultures. Biochem. Pharmacol., 48, 1225-1230.
57. Yamaguchi, M. & Kishi, S. (1996). Zinc compounds inhibit osteoclast-like cell formation at the earlier stage of rat marrow culture but not osteoclast function. Mol. Cell. Biochem., 158, 171-177.
58. Yamaguchi, M. & Kishi, S. (1995). Inhibitory effect of zinc-chelating dipeptide on parathyroid hormone-stimulated osteoclast-like cell formation in mouse marrow cultures: Involvement of calcium signaling. Peptides, 16, 629-633.
59. Zaidi, M., Blair, H. C., Moonga, B. S., Abe, E. & Huang, C. L. H. (2003). Osteoclastogenesis, bone resorption, and osteoclast-based therapeutics. J. Bone Miner. Res., 18, 599-609.
60. Asagiri, M. & Takayanagi, H. (2007). The molecular understanding of osteoclast differentiation. Bone, 40, 251-264.
61. Anderson, D. M., Marashovsky, E., Billingoley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D. & Galibert, L. (1997). A homologue of the TNF receptor and its ligand enhances T-cell growth an dentritic-cell function. Nature (London), 390, 175-179.
62. Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., Tsuda, E., Morinaga, T., Higashio, K., Udagawa, N., Takahashi, N. & Suda, T. (1998). Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci., USA, 95, 3597-3602.
63. Tsuda, E., Goto, M., Mochizuki, S., Yano, K., Kobayashi, F., Morinaga, T. & Higashio, K. (1997). Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem. Biophys. Res. Commun., 234, 137-142.
64. Inoue, J., Ishida, T., Tsukamoto, N., Kobayashi, N., Naito, A., Azuma, S. &Yamamoto, T. (2000). Tumor necrosis factor receptor-associated factor (TRAF) family: adaptor proteins that mediate cytokine signaling. Exp. Cell Res., 254, 14-24.
65. Yamaguchi, M. & Uchiyma, S. (2004). Receptor activator of Nf-κB ligand (RANKL)-stimulated osteoclastogenesis in mouse marrow culture is suppressed by zinc in vitro. Int. J. Mol. Med., 14, 81-85.
66. Zou, W., Hikim, I., Tschoep, K., Endres, S., Zvi, B. S. (2001). Tumor necrosis factor-mediated RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism. J. Cell. Biochem., 83, 70-83.
67. Ma, Z. J. & Yamaguchi, M. (2000). Alteration in bone components with increasing age of newborn rats: role of zinc in bone growth. J. Bone Miner. Metab., 18, 264-270.
68. Ma, Z. J. & Yamaguchi, M. (2001). Role of endogenous zinc in the enhancement of bone protein synthesis associated with bone growth of newborn rats. J. Bone Miner. Metab., 19, 38-44.
69. Ma, Z. J., Misawa, H. & Yamaguchi, M. (2001). Stimulatory effect of zinc on insulin-like growth factor-I and transforming growth factor-β1 production with bone growth of newborn rats. Int. J. Mol. Med., 8, 623-628.
70. Gabbitas, B., Pash, J. & Canalis, E. (1994). Regulation of insulin-like groth factor-II synthesis in bone cell cultures by skeletal growth factors. Endocrinology, 135, 284-289.
71. Asahina, I., Sampath, T. K., Nishimura, I. & Hauschka, P. V. (1999). Human osteogenic protein-1 induces both chondroblastic and osteoblastic differentiation of osteoprogenitor cells derived from newborn rat calvaria. J. Cell Biol., 123, 921-933.
72. Ma, Z. J. & Yamaguchi, M. (2001). Stimulatory effect of zinc and growth factor on bone protein component in newborn rats: Enhancement with zinc and insulin-like growth factor-I. Int. J. Mol. Med., 7, 73-78.
73. Ma, Z. J. & Yamaguchi, M. (2001). Stimulatory effect of zinc on deoxyribonucleic acid synthesis in bone growth of newborn rats: Enhancement with zinc and insulin-like growth factor-I. Calcif. Tissue Int., 69, 158-163.
74. Barnes, G. L., Kostenuik, P. J., Gerstenfeld, L. C. & Eihorn, T. A. (1999). Growth factor regulation of fracture repair. J. Bone Miner. Res. 14, 1805-1815.
75. Eihorn, T. A. (1998). The cell and molecular biology of fracture healing. Clin. Orthop., 355, S7-S21.
76. Bolander, M. E. (1998). Regulation of fracture repair by growth factors. Proc. Soc. Exp. Biol. Med., 200, 165-170.
77. Igarashi, A. & Yamaguchi, M. (1999). Increase in bone protein components with healing rat fractures: Enhancement by zinc treatment. Int. J. Mol. Med., 4, 615-620.
78. Igarashi, A. & Yamaguchi, M. (2001). Increase in bone growth factors with healing rat fractures: The enhancing effect of zinc. Int. J. Mol. Med., 8, 433-438.
79. Igarashi, A. & Yamaguchi, M. (2002). Characterization of the increase in bone 66 kDa protein component with healing rat fractures: Stimulatory effect of zinc. Int. J. Mol. Med., 9, 503-508.
80. Igarashi, A. & Yamaguchi, M. (2003). Great increase in bone 66 kDa protein and osteocalcin at later stage with healing rat fractures: Effect of zinc treament. Int. J. Mol. Med., 11, 223-228.
81. Yamaguchi, M., Igarashi, A., Misawa, H. & Tsurusaki, Y. (2003). Enhancement of albumin expression in bone tissues with healing rat fractures. J. Cell. Biochem., 89, 356-363.
82. Ishida, K., Sawada, N. & Yamaguchi, M. (2004). Expression of albumin in bone tissues and osteoblastic cells: Involvement of hormone regulation. Int. J. Mol. Med., 14, 891-895.
83. Ishida, K. & Yamaguchi, M. (2004). Role of albumin in ostoblastic cells: Enhancement of cell proliferation and suppression of alkaline phosphatase activity. Int. J. Mol. Med., 14, 1077-1081.
84. Ishida, K. & Yamaguchi, M. (2005). Albumin regulates Runx2 and α1 (I) collagen mRNA expression in osteoblastic cells: Comparison with insulin-like growth factor-I. Int. J. Mol. Med., 16, 689-694.
85. Yamaguchi, M., Ozaki, K. & Suketa, Y. (1989). Alteration in bone metabolism with increasing age: Effects of zinc and vitamin D3 in aged rats. J. Pharmacobio-Dyn., 12, 67-73.
86. Yamaguchi, M. & Ozaki, K. (1990). Aging affects cellular zinc and protein synthesis in the femoral diaphysis of rats. Res. Exp. Med., 190, 295-300.
87. Yamaguchi, M. & Ehara, Y. (1995). Zinc decrease and bone metabolism in the femoral-metaphyseal tissues of rats with skeletal unloading. Calcif. Tissue Int., 57, 218-223.
88. Yamaguchi, M. & Ehara, Y. (1996). Effect of essential trace metal on bone metabolism in the femoral-metaphyseal tissues of rats with skeletal unloading: Comparison with zinc-chelating dipeptide. Calcif. Tissue Int., 59, 27-32.
89. Morey, E. R. & Baylink, D. J. (1978). Inhibition of bone formation during spaceflight. Science, 201, 1138-1141.
90. Yamaguchi, M. & Ozaki, K. (1990). A new zinc compound, β-alanyl-L-histidinato zinc, stimulates bone growth in weanling rats. Res. Exp. Med., 190, 105-110.
91. Yamaguchi, M. & Miwa, H. (1991). Stimulatory effect of beta-alanyl-L-histidinato zinc on bone formation in tissue culture. Pharmacology, 42, 230-240.
92. Samuchson, J. (1967). Mechanism for the exchange of the calcium in bone mineral. Nature (London), 216, 193-194.
93. Yamaguchi, M. & Ohtaki, J. (1991). Effect of beta-alanyl-L-histidinato zinc on osteoblastic MC3T3-E1 cells: Increases in alkaline phosphatase and proliferation. Pharmacology, 43, 225-232.
94. Yamaguchi, M. & Kishi, S. (1994). Effect of zinc-chelating dipeptide on bone metabolism in weanling rats: Comparison with β-alanyl-L-histidinato zinc-related compounds. Peptides, 15, 671-673.
95. Yamaguchi, M. & Kishi, S. (1994). Comparison of the effect of β-alanyl-L-histidinato zinc and its zinc-chelating ligand on bone metabolism in tissue culture. Biol. Pharm. Bull., 17, 522-526.
96. Yamaguchi, M. & Ozaki, K. (1990). Effect of the new zinc compound beta-alanyl-L-histidinato zinc on bone metabolism in elderly rats. Pharmacology, 41, 345-349.
97. Kishi, S. & Yamaguchi, M. (1994). Stimulatory effect of β-alanyl-L-histidinato zinc on alkaline phosphatase activity in bone tissue from elderly rats: Comparison with zinc sulfate action. Biol. Pharm. Bull., 17, 345-347.
98. Yamaguchi, M., Ozaki, K. & Hoshi, T. (1990). β-Alanyl-L-histidinato zinc prevents skeletal unloading-induced disorder of bone metabolism in rats. Res. Exp. Med., 190, 289-294.
99. Maloney, N. A., Ott, S. M., Alfrey, A. C., Miller, N. L., Coburn, J. W. & Sherrard, D. J. (1982). Histological quantitation of aluminium in iliac from patients with renal failure. J. Lab. Clin. Med., 99, 206-216.
100. Yamaguchi, M. & Ozaki, K. (1990). Beta-alanyl-L-histidinato zinc prevents the toxic effect of aluminium on bone metabolism in weanling rats. Pharmacology, 41, 338-344.
101. Segawa, Y., Tsuzuike, N., Tagashira, E. & Yamaguchi, M. (1992). Preventive effect of β-alanyl-L-histidinato zinc on bone metabolism in rats fed on low-calcium and vitamin D-deficient diets. Res. Exp. Med., 192, 213-219.
102. Segawa, Y., Tsuzuike, N., Itokazu, Y., Tagashira, E. & Yamaguchi, M. (1993). Effect of β-alanyl-L-histidinato zinc on bone metabolism in rats with adjuvant arthritis. Biol. Pharm. Bull.,16, 656-659.
103. Pock, W. A. (1984). The effects of glucocorticoids on bone cell metabolism and function. Adv. Exp. Med. Biol., 171, 111-119.
104. Segawa, Y., Tsuzuike, N., Itokazu, Y., Tagashira, E. & Yamaguchi, M. (1992). β-Alanyl-L-histidinato zinc prevents hydrocortisone-induced disorder of bone metabolism in rats. Res. Exp. Med., 192, 317-322.
105. Johnston, C. C. Jr., Hui, S. L., Witt, R. M., Appledonn, R., Baker, R. S. & Longcope, C. (1985). Early menopausal changes in bone mass and sex steroids. J. Clin. Endocrinol. Metab., 61, 905-911.
106. Goulding, A. & Gold, E. (1987). Effects of chronic prednisolone treatment on bone resorption and bone composition in intact and ovariectomized rats receiving β-estradiol. Endocrinology, 122, 482-487.
107. Segawa, Y., Tsuzuike, N., Tagashira, E. & Yamaguchi, M. (1993). Preventive effect of β-alanyl-L-histidinato zinc on the deterioration of bone metabolism in ovariectomized rats. Biol. Pharm. Bull., 16, 486-489.
108. Yamaguchi, M. & Kishi, S. (1993). Prolonged administration of β-alanyl-L-histidinato zinc prevents bone loss in ovariectomized rats. Jap. J. Pharmacol., 63, 203-207.
109. Kishi, S., Segawa, Y. & Yamaguchi, M. (1994). Histomorphological confirmation of the preventive effect of β-alanyl-L-histidinato zinc on bone loss in ovariectomized rats. Biol. Pharm. Bull., 17, 862-865.
110. Yamaguchi, M. & Gao, Y.H. (1998). Potent effect of zinc acexamate on bone components in the femoral-metaphyseal tissues of elderly female rats. Gen. Pharmacol., 30, 423-427.
111. Hui, S. L., Epstein, S. & Johanston, C. C. (1985). A prospective study of bone mass in patients with type I diabetes. J. Clin. Endocrinol. Metab., 60, 74-80.
112. Mcnair, P. (1988). Bone mineral metabolism in human type I diabetes mellitus. Dan. Med. Bull., 35, 109-121.
113. Yamaguchi, M. & Uchiyama, S. (2003). Preventive effect of zinc acexamate administration in streptozotocin-diabetic rats: Restoration of bone loss. Int. J. Mol. Med., 12, 755-761.
114. Uchiyama, S. & Yamaguchi, M. (2003). Alteration in serum and bone component findings induced in streptozotocin-diabetic rats is restored by zinc acexamate. Int. J. Mol. Med., 12, 949-954.
115. Igarashi, A. & Yamaguchi, M. (1999). Stimulatory effect of zinc acexamate administration on fracture healing of the femoral-diaphyseal tissues in rats. Gen. Pharmacol., 32, 463-469.
116. Yamaguchi, M. (1995). β-Alanyl-L-histidinato zinc: A potent activator in bone formation. Curr. Med. Chem., 1, 356-365.
117. Yamaguchi, M. (1995). β-Alanyl-L-histidinato zinc and bone resorption. Gen. Pharmac., 26, 1179-1183.
118. Yamaguchi, M. (1998). Role of zinc in bone formation and bone resorption. J. Trace Elem. Exp. Med., 11, 119-135.
119. Yamaguchi, M. (2004). Role of zinc in regulation of osteoclastogenesis. Biomed Res Trace Elements 15, 9-14.
120. Yamaguchi, M., Igarashi, A. & Uchiyama, S. (2004). Bioavailability of zinc yeast in rats: Stimulatory effect on bone calcification in vivo. J. Health Sci., 50, 75-81.
121. Yamaguchi, M. & Gao, Y. H. (1997). Anabolic effect of genistein on bone metabolism in the femoral-metaphyseal tissues of elderly rats is inhibited by the anti-estrogen tamoxifen. Res. Exp. Med., 197, 101-107.
122. Yamaguchi, M. & Gao, Y. H. (1998). Anabolic effect of genistein and genistin on bone metabolism in the femoral-metaphyseal tissues of elderly rats: The genistein effect is enhanced by zinc. Mol. Cell. Biochem., 178, 377-382.
123. Kuiper, G. G., Lemmen, J. G., Carlsson, B., Corton, J. C., Safe, S. H., van der Saag, P. T., van der Burg, B. & Gustafsson, J. A. (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology, 139, 4252-4263.
124. Gao, Y. H. & Yamaguchi, M. (1999). Anabolic effect of daizein on cortical bone in tissue culture: Comparison with genistein effect. Mol. Cell. Biochem., 194, 93-98.
125. Yamaguchi, M., Zhong, J. M. & Fushimi, T. (2002). Anabolic effect of phosphogenistein and phosphodaidzein on bone components in rat femoral-metaphyseal tissues in vitro. J. Bone Miner. Metab., 20, 148-155.
126. Yamaguchi, M. & Ma, Z. J. (2001). Effect of polyphenols on calcium content and alkaline phosphatase activity in rat femoral tissues in vitro. Biol. Pharm. Bull., 24, 1437-1430.
127. Sugimoto, E. & Yamaguchi, M. (2000). Anabolic effect of genistein is osteoblastic MC3T3-E1 cells. Int. J. Mol. Med., 5, 515-520.
128. Sugimoto, E. & Yamaguchi, M. (2000). Stimulatory effect of daidzein in osteoblastic MC3T3-E1 cells. Biochem. Pharmacol., 59, 471-475.
129. Yamaguchi, M. & Sugimoto, E. (2000). Stimulatory effect of genistein and daizein on protein synthesis in osteoblastic MC3T3-E1 cells: Activation of aminoacyl-tRNA synthetase. Mol. Cell. Biochem., 214, 97-102.
130. Yamaguchi, M. & Weitzmann, M. N. (2009). The estrogen 17β-estradiol and phytoestrogen genistein mediate differential effects on osteoblastic NF-κB activity. Int. J. Mol. Med., 23, 297-301.
131. Yamaguchi, M. & Gao, Y. H. (1998). Inhibitory effect of genistein on bone resorption in tissue culture. Biochem. Pharmacol., 55, 71-76.
132. Gao, Y. H. & Yamaguchi, M. (1999). Inhibitory effect of genistein on osteoclast-like cell formation in mouse marrow cultures. Biochem. Pharmacol., 58, 767-772.
133. Gao, Y. H. & Yamaguchi, M. (1999). Suppressive effect of genistein on rat bone osteoclasts: Apoptosis is induced through Ca2+ signaling. Biol. Pharm. Bull., 22, 805-809.
134. Gao, Y. H. & Yamaguchi, M. (2000). Suppressive effect of genistein on rat bone osteoclasts: Involvement of protein kinase inhibition and protein tyrosine phosphatase activation. Int. J. Mol. Med., 5, 261-267.
135. Takahashi, N., Yamana, H., Yoshiki, S., Roodman, G. D., Mundy, G. R., Jones, S. J., Boyde, A. & Suda, T. (1988). Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology, 122, 1373-1382.
136. Liu, Y., Bhalla, K., Hill, C. & Priest, D. G. (1994). Evidence for involvement of tyrosine phosphorylation in taxol-induced apoptosis in a human ovarian tumor cell line. Biochem.Pharmacol., 48, 1265-1272.
137. Murrills, R. J., Shane, E., Lindsay, R. & Dempster, D. W. (1989). Bone resorption by isolated human osteoclasts in vitro: effects of calcitonin. J. Bone Miner. Res., 4, 259-268.
138. Su, Y., Charkrabort, M., Nathanson, M. H. & Baron, R. (1992). Differential effects of the 3', 5'-cyclic adenosine monophosphate and proein kinase C pathways on the response of isolated rat osteoclasts to calcitonin. Endocrinology, 131, 1497-1502.
139. Jones, D. O. P., McConkey, D. J., Nicotera, P. & Orrenius, S. (1989). Calcium-activated DNA fragmentation in rat liver nuclei. J. Biol. Chem., 264, 6398-6403.
140. McCabe, M. J. & Orrenius, S. (1993). Genistein induces apoptosis in immature human thymocytes by inhibiting topoisomerase-II. Biochem. Biophys. Res. Commun., 194, 944-950.
141. Missbach, M., Jeschke, M., Feyen, J., Muller, K., Glatt, M., Green, J. & Susa, M. (1999). A novel inhibitor of the tyrosine kinase Src suppresses phosphoryalation of its major cellular substrates and reduces bone resorption in vitro and in rodent models in vivo. Bone, 24, 437-449.
142. Hunter, T. (1995). Protein kinases and phosphatases: the Yin and Yang of protein phosphorylation and signaling. Cell, 80, 225-236.
143. Aoki, K., Didomenico, E., Sims, N. A., Mukhopadhyay, K., Neff, L., Houghton, A., Amling, M., Levy, J. B., Horne, W. C. & Baron, R. (1999). The tyrosine phosphatase SHP-1 is a negative regulator of osteoclastogenesis and osteoclast resorbing activity: increased resorption and osteopenia in mev.mev mutant mice. Bone. 25, 261-267.
144. Ono, R. & Yamaguchi, M. (1999). Increase in bone components of rats orally administered isoflavone-containing soybean extract (nijiru). J. Health Sci., 45, 66-69.
145. Ono, R. & Yamaguchi, M. (1999). Anabolic effect of soybean saponin on bone components in the femoral tissues of rats. J. Health Sci., 45, 251-255.
146. Ono, R., Ma, Z. J. & Yamaguchi, M. (2000). Prolonged intake of fermented soybean diets with supplementation of isoflavone and saponin prevents bone loss in ovariectomized rats. J. Health Sci., 46, 70-74.
147. Yamaguchi, M., Ono, R. & Ma, Z. J. (2001). Prolonged intake of isoflavone-and saponin-containing soybean extract (nijiru) supplement enhances circulating γ-carboxylated osteocalcin concentration in healthy individuals. J. Health Sci., 47, 579-582.
148. Gao, Y. H. & Yamaguchi, M. (1998). Zinc enhancement of genistein's anabolic effect on bone components in elderly female rats. Gen. Pharmacol., 31, 199-202.
149. Yamaguchi, M., Gao, Y. H. & Ma, Z. J. (2000). Synergistic effect of genistein and zinc on bone components in the femoral-metaphyseal tissues of female rats. J. Bone Miner. Metab., 18, 77-83.
150. Ma, Z. J., Igarashi, A., Inagaki, M., Mitsugi, F. & Yamaguchi, M. (2000). Supplemental intake of isoflavones and zinc-containing mineral mixture enhances bone components in the femoral tissues of rats with increasing age. J. Health Sci., 46, 363-369.
151. Uchiyama, S. & Yamaguchi, M. (2007). Genistein and zinc synergistically enhance gene expression and mineralization in osteoblastic MC3T3-E1 cells. Int. J. Mol. Med., 19, 213-220.
152. Uchiyama, S. & Yamaguchi, M. (2007). Genistein and zinc synergistically stimulate apoptotic cell death and suppress RANKL siganling-related gene expression in osteoclastic cells. J. Cell. Biochem., 101, 529-542.
153. Darnay, B. G., Ni, J., Moore, P. A. & Aggarwal, B. B. (1999). Activation of NF-κB by RANK require tumor necrosis factor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF-6 interaction motif. J. Biol. Chem., 274, 7724.
154. Kim, K., Kim, J. H., Lee, J., Jim, H. M., Lee, S. H., Fisher, D. E., Kook, H., Kim, K. K., Choi, Y. & Kim, N. (2005). Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis. J. Biol. Chem., 280, 35209-35216.
155. Ma, Z. J., Shimanuki, S., Igarashi, A., Kawasaki, Y. & Yamaguchi, M. (2000). Preventiv effect of dietary fermented soybean on bone loss in ovariectomized rats: Enhancement with isoflavone and zinc supplementation. J. Health Sci., 46, 263-268.
156. Yamaguchi, M., Igarashi, A., Sakai, M., Degawa, H. & Ozawa, Y. (2005). Prolonged intake of dietary fermented isoflavone-rich soybean reinforced with zinc affects circulating bone biochemical markers in aged individuals. J. Health Sci., 51, 191-196.
157. Shea, M. K. & Booth, S. L. (2008). Update on the role of vitamin K in skeletal health. Nutr. Rev., 66, 549-557.
158. Knapen, M. H. J., Hamulyak, K. & Vermeer, C. (1989). The effect of vitamin K supplementation on circulating osteocalcin (bone gla protein) and urinary calcium excretion. Ann. Intern Med., 111, 1001-1005.
159. Hart, J. P., Sheaver, M. J., Klenerman, L., Catterall, A., Reeve, J., Sambrook, P. N., Dodds, R. A., Bitensky, L. & Chayen, J. (1985). Electrochemical detection of depressed circulating levels of vitamin K1 in osteoporosis. J. Clin. Endocrinol. Metab., 60, 1268-1269.
160. Koshihara, Y., Hoshi, K. & Shiraki, M. (1992). Enhancement of mineralization of human osteoblasts by vitamin K2 (menaquinone-4). J. Clin. Exp. Med., 161, 439-440.
161. Hauschka, P. V., Lian, J. B. & Gallop, P. M. (1975). Direct identification of the calcium-binding amino acid, γ-carboxyglutamate, in mineralized tissue. Proc. Natl. Acad. Sci. USA, 72, 3925-3929.
162. Price, P. A. (1985). Vitamin k-dependent formation of bone gla protein (osteocalcin) and its function. Vitam. Horm., 42, 65-108.
163. Hauschka, P. V. & Carr, S. A. (1982). Calcium-dependent α-helical structure in osteocalcin. Biochemistry, 21, 2538-2547.
164. Hara, K., Akiyama, Y., Nakamura, T., Murota, S. & Morita, I. (1995). The inhibitory effect of vitamin K2 (menaquinone) on bone resorption may be related to its side chain. Bone, 16, 179-184.
165. Akiyama, Y., Hara, K., Ohkawa, I. & Tajima, T. (1993). Effects of menaterenone on bone loss induced by ovariectomy in rats. Jpn. J. Pharmacol., 62, 145-153.
166. Hosoi, T. (1996). Recent progress in treatement of osteoporosis. Nippon Ronnen Igaku Zasshi 33, 240-244.
167. Ehara, Y., Takahashi, H., Hanahisa, Y. & Yamaguchi, M. (1996). Effect of vitamin K2 (menaquinone-7) on bone metabolism in the femoral-metaphyseal tissues of normal and skeletal-unloaded rats: enhancement with zinc. Res. Exp. Med., 196, 171-178.
168. Yamaguchi, M., Uchiyama, S. & Tsukamoto, Y. (2002). Stimulatory effect of menaquinone-7 on bone formation in elderly female rat femoral tissues in vitro: Prevention of bone deterioration with aging. Int. J. Mol. Med., 10, 720-733.
169. Yamaguchi, M., Sugimoto, E. & Hachiya, S. (2001). Stimulatory effect of menaquinone-7 (vitamin K2) on osteoblastic bone formation in vitro. Mol. Cell. Biochem., 223, 131-137.
170. Yamaguchi, M. & Ma, Z.J. (2001). Inhibitory effect of menaquinone-7 (vitamin K2) on osteoclast-like cell formation and osteoclastic bone resorption in rat bone tissues in vitro. Mol. Cell. Biochem., 228, 39-47.
171. Yamaguchi, M., Taguchi, H., Gao, Y. H., Igarashi, A. & Tsukamoto, Y. (1999). Effect of vitamin K2 (menaquinone-7) in fermented soybean (natto) on bone loss in ovariectomized rats. J. Bone Miner. Metab., 17, 23-29.
172. Yamaguchi, M., Kakuda, H., Gao, Y. H. & Tsukamoto, Y. (2000). Prolonged intake of fermented soybean (natto) diets containing vitamin K2 (menaquinone-7) prevents bone loss in ovariectomized rats. J. Bone Miner. Metab., 18, 71-76.
173. Tsukamoto, Y., Ichise, H. & Yamaguchi, M. (2000). Prolonged intake of dietary fermented soybeans (natto) with the reinforced vitamin K2 (menaquinone-7) enhances circulating Γ-carboxylated osteocalcin concentration in normal individuals. J. Health Sci., 46, 317-321.
174. Tsukamoto, Y., Ichise, H., Kakuda, K. & Yamaguchi, M. (2000). Intake of fermented soybean (natto) increases circulating vitamin K2 (menaquinone-7) and-carboxylated osteocalcin concentration in normal individuals. J. Bone Miner. Metab., 18, 216-222.
175. Ma, Z. J., Igarashi, A., Yamakawa, K. & Yamaguchi, M. (2001). Enhancing effect of zinc and vitamin K2 (menaquinone-7) on bone components in the femoral tissues of female elderly rats. J. Health Sci., 47, 40-45.
176. Promislow, J. H. E., Goodman-Gruen, D., Slymen, D. J. & Barret-Connor, E. (2002). Retinol intake and bone mineral density in the elderly: the rancho brenardo study. J. Bone Miner. Res., 17, 1349-1358.
177. Yamaguchi, M. & Uchiyama, S. (2003). Effect of carotenoid on calcium content and alkaline phosphatase activity in rat femoral tissues in vitro: The unique anabolic effect of β-cryptoxanthin. Biol. Pharm. Bull., 26, 1188-1191.
178. Yamaguchi, M., Hamamoto, R., Uchiyama, S. & Ishiyama, K. (2008). Effects of flavonoid on calcium content in femoral tissue culture and parathyroid hormone-stimulated osteoclastogenesis in bone marrow culture in vitro. Mol. Cell. Biochem., 303, 83-88.
179. Yamaguchi, M. & Uchiyama, S. (2004). β-Cryptoxanthin stimulates bone formation and inhibits bone resorption in tissue culture in vitro. Mol. Cell. Biochem., 258, 137.
180. Klein-Nulend, J., Fall, P. M. & Raisz, L. G. (1990). Comparison of the effects of synthetic human parathyroid hormone (PTH)-(1-34)-related peptide of malignancy and bovine PTH-(1-34) on bone formation and resorption in organ culture. Endocrinology, 126, 223-227.
181. Graves, L. III & Jilka, R. L. (1990). Comparison of bone and parathyroid hormone as stimulators of osteoclast development and activity in calvarial cell cultures from normal and osteopetrotic (mi/mi) mice. J. Cell. Physiol., 145, 102-109.
182. Klein, D. C. & Raisz, L. G. (1970). Prostaglanidins: stimulation of bone resorption in tissue culture. Endocrinology, 86, 1436-1440.
183. McEligot, A. J., Rock, C. L., Shanks, T. G., Flatt, S. W., Newman, V., Farber, S. & Pierce, J.P. (1999). Comparison of serum carotenoid responses between women consuming vegetable juice and women consuming raw or cooked vegetable. Cancer Epideminol. Biomarkers Prev., 8, 227-231.
184. Uchiyama, S. & Yamaguchi, M. (2005). β-Cryptoxanthin stimulates cell proliferation and transcriptional activity in osteoblastic MC3T3-E1cells. Int. J. Mol. Med., 15, 675.
185. Uchiyama, S. & Yamaguchi, M. (2005). β-Cryptoxanthin stimulates cell differentiation and mineralization in osteoblastic MC3T3-E1 cells. J. Cell. Biochem., 95, 1224-1234.
186. Centrella, M., McCarthy, T. L. & Canalis, E. (1990). Receptors for insulin-like growth factor-I and-II in osteoblast-enriched cultures from fetal rat bone. Endocrinology, 126, 39-44.
187. Palcy, S., Bolivar, I. & Goltzman, D. (2000). Role of activator protein 1 transcriptional activity in the regulation of gene expression by transforming growth factor β1 and bone morphogenic protein 2 in ROS 17/2.8 osteoblast-like cells. J. Bone Miner, Res., 15, 2352-2361.
188. Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R. T., Gao, Y. H., Inada, M., Sato, M., Okamoto, R., Kitamura, Y., Yoshiki, S. & Kishimoto, T. (1997). Targeted disruption of Cbfa1 results in a comple lack of bone formation owing to maturational arrest of osteoblasts. Cell, 89, 755-764.
189. Yohay, D. A., Zhang, J., Thrailkill, K. M., Arthur, J. M. & Quarles, L. D. (1994). Role of serum in the developmental expression of alkaline phosphatase in MC3T3-E1 osteoblasts. J. Cell. Physiol., 158, 467-475.
190. Park, C. K., Ishimi, Y., Ohmura, M., Yamaguchi, M. & Ikegami, S. (1997). Vitamin A and carotenoid stimulate differentiation of mouse osteoblstic cells. J. Nutr. Sci. Vitaminol., 43, 281-296.
191. Zaidi, M., Blair, H. C., Moonga, B. S., Abe, E. & Huang, C. L.-H. (2003). Osteoclastogenesis, bone resorption, and osteoblast-based therapeutics. J. Bone Miner. Res., 18, 599.
192. Tanaka,S., Nakamura,I., Inoue, J.-I., Oda, H. & Nakamura, K. (2003). Osteoclastogenesis, bone resorption, and osteoclast-based therapeutics. J. Bone Miner. Res., 18, 599-609.
193. Uchiyama, S. & Yamaguchi, M. (2004). Inhibitory effect of β-cryptoxanthin on osteoclast-like cell formation in mouse marrow cultures. Biochem. Pharmacol., 67, 1297-1305.
194. Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D. & Gailibert, L. (1997). A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature, 390, 175-195.
195. Lee, Z. H., Kwack, K., Kim, K. K., Lee, S. H. & Kim, H.-H. (2000). Activation of c-Jun N-terminal kinase and activator protein 1 by receptor activator of NF-κB. Mol Pharmacol., 58, 1536-1545.
196. Uchiyama, S. & Yamaguchi, M. (2006). β-Cryptoxanthin stimulates apoptotic cell death and suppresses cell function in osteoclastic cells: Change in their related gene expression. J. Cell. Biochem., 98, 1185-1195.
197. Uchiyama S., Ishiyama K., Hashimoto K. & Yamaguchi M. (2005). Synergistic effect ofβ-cryptoxanthin and zinc sulfate on the bone component in rat femoral tissues in vitro: The unique anabolic effect with zinc. Biol. Pharma. Bull., 28, 2142-2145.
198. Uchiyama, S. & Yamaguchi, M. (2008). Anabolic effect of β-cryptoxanthin in osteoblastic MC3T3-E1 cells is enhanced with 17 β-estradiol, genistein, or zinc sulfate in vitro: the unique effect with zinc on Runx2 and α1 (I) collagen mRNA espression. Mol. Cell. Biochem., 307, 209-219.
199. Yamaguchi M. and Uchiyama S. (2008). Combination of β-cryptoxanthin and zinc has potent effects on apoptotic cell death and suppression of bone resorption-related gene expression in osteoclastic cells. Int. J. Mol. Med., 22, 221-228.
200. Yamaguchi, M., Uchiyama, S., Ishiyama, K. & Hashimoto, K. (2006). Oral administration in combination with zinc enhances β-cryptoxanthin-induced anabolic effects on bone components in the femoral tissues of rats in vivo. Biol. Pharm. Bull., 29, 371-374.
201. Uchiyama, S., Sumida T. & Yamaguchi M. (2004). Oral administration ofβ-cryptoxanthin induces anabolic effects on bone components in the femoral tissues of rats in vivo. Biol. Pharm. Bull., 27, 232-235.
202. Uchiyama, S.; Sumida, T. & Yamaguchi, M. (2004). Anabolic effect ofβ-cryptoxanthin on bone components in the femoral tissues of aged rats in vivo and in vitro. J. Health Sci., 50, 491-496.
203. Uchiyama, S. & Yamaguchi, M. (2005). Oral administration of β-cryptoxanthin prevents bone loss in streptozotocin-diabetic rats in vivo. Biol. Pharm. Bull., 28, 1766-1769.
204. Uchiyama, S. & Yamaguchi, M. (2006). Oral administration of β-cryptoxanthin prevents bone loss in ovariectomized rats. Int. J. Mol. Med., 17, 15-20.
205. Levy, J. R., Murray, E., Manolagass, S. & Olefsky, J. M. (1986). Demonstration of insulin receptors and modulation of alkaline phosphatase activity by insulin in rat osteoblastic cells. Endocrinology, 119, 1786-1792.
206. Hallen, J. M., Alatalo, S, L., Suminen, H., Cheng, S., Janekila, A. J. & Vaananen, H. K. (2000). Tartrate-resistant acid phosphatase 5b: A novel serum marker of bone resorption. J. Bone Miner. Res., 15, 1337-1345.
207. Clements, J. D., Herrick, M. V., Singer, F. R. & Eyre, D. R. (1997). Evidence that serum NTx (collagen-type I N-telopeptides) can act as an immunochemical marker of bone resorption. Clin. Chem., 43, 2058-2063.
208. Yamaguchi, M., Igarashi, A., Uchiyama, S., Morita, S., Sugawara, K. & Sumida, K. (2004). Prolonged intake of juice (Citrus unshiu) reinforced withβ-cryptoxanthin has an effect on circulating bone biochemical markers in normal individuals. J. Health Sci., 50, 619-624.
209. Yamaguchi, M., Igarashi, A., Morita, S., Sumida, T. & Sugawara, K. (2005). Relationship between serumβ-cryptoxanthin and circulating bone metabolic markers in healthy individuals with the intake of juice (Citrus unshiu) containingβ-cryptoxanthin. J. Health Sci., 51, 738-743.
210. Yamaguchi, M., Igarashi, A., Uchiyama, S., Sugawara, K., Sumida, T., Morita, S., Ogawa, H., Nishitani, M. & Kajimoto, Y. (2006). Effect of β-cryptoxanthin on circulating bone metabolic markers: Intake of juice (Citrus unshiu) supplemented with β-cryptoxanthin has an effect in menopausal women. J. Health Sci., 52, 758-768.
211. Wang, Y., Hodge, A. M., Wluka, A. E., English, D. R., Giles, G. G., O'Sullivan, R., Forbes, A. & Cicuttini, F. M. (2007). Effect of antioxidants on knee cartilage and bone in healthy, middle-aged subjects: a cross-sectional study. Arthritis Res. Ther., 9, R66.
212. Sugiura, M., Nakamura, M., Ogawa, K., Ikoma, Y., Ando, F. & Yano, M. (2008) Bone mineral density in post-menopausal female subjects is associated with serum antioxidant carotenoids. Osteoporos. Int., 19, 211-219-720.
213. Granado-Lorencio, F., Olmedilla-Alonso, B., Herrero-Barbudo, C., Blanco-Navarro, I. & Perez-Sacristan, B. (2008). Seasonal variation of serum alpha-and beta-cryptoxanthin and 25-OH-vitamin D(3) in women with osteoporosis. Osteoporos. Int., 19, 717-720.
214. Lai, Y. L. & Yamaguchi, M. (2006). Phytocomponent p-hydroxycinnamic acid stimulates bone formation and inhibits bone resorption in rat femoral tissues in vitro. Mol. Cell. Biochem., 292, 45-52.
215. Yamaguchi, M., Lai, Y.L., Uchiyama, S. & Nakagawa, T. (2008). Phytocomponent p-hydroxycinnamic acid stimulates mineralization in osteoblastic MC3T3-E1 cells. Int. J. Mol. Med., 22, 287-291.
216. Lai, Y. L. & Yamaguchi, M. (2007). Phytocomponent p-hydroxycinnamic acid inhibits osteoclast-like cell formation in mouse bone marrow cultures. Int. J. Mol. Med., 19, 123-128.
217. Lai, Y. L. & Yamaguchi, M. (2006). Oral administration of phytocomponent p-hydroxycinnamic acid has anabolic effects on bone calcification in femoral tissues of rats in vivo. J. Health Sci., 52, 308-312.
218. Yamaguchi, M., Lai, Y. L., Uchiyama, S. & Nakagawa, T. (2008). Oral administration of phytocomponent p-hydroxycinnamic acid prevents bone loss in ovariectomized rats. Mol. Cell. Biochem., 311, 31-36.
219. Lai, Y. L. & Yamaguchi, M. (2007). Oral administration of phytocomponent p-hydroxycinnamic acid has a preventive effect on bone loss in streptozotocin-induced diabetic rats. Int. J. Mol. Med., 19, 803-807.
220. Suzuki, T., Nakayama, H. & Yamaguchi, M. (1997). Effect of wasabi leafstalk (Wasabia japonica MATSUM.) extract on bone metabolism in mouse calvaria tissue culture. Food Sci. Technol. Int. Tokyo, 3, 366-369.
221. Suzuki, M. & Yamaguchi, M. (2003). Stimulatory effect of wasabi leafstalk extract (Wasabia japonica MATSUM.) on bone calcification: Interaction with bone anabolic factors in mouse calvaria tissue in vitro. Food Sci. Technol. Res., 9, 87-90.
222. Suzuki, T. & Yamaguchi, M. (1999). Characterization of stimulatory effect of wasabi leafstalk (Wasabia japonica MATSUM.) extract on bone calcification in mouse calvaria tissue cutlture. Food Sci. Technol. Res., 5, 304-307.
223. Suzuki, T. & Yamaguchi, M. (2004). Purification of active component in wasabi leafstalk (Wasabia japonica MATSUM) extract in stimulating bone calcification in vitro. J. Health Sci., 50, 483-490.
224. Suzuki, T. & Yamaguchi, M. (1999). Anabolic effect of wasabi leafstalk (Wasabia japonica MATSUM.) extract on bone metabolism in rats. Food Sci. Technol. Res., 5, 61-63.
225. Yamaguchi, M., Ma, Z. J. & Suzuki, T. (2003). Anabolic effect of wasabi leafstalk (Wasabia japonica MATSUM.) extract on bone components in the femoral-diaphyseal and-metaphyseal tissues of aged female rats in vitro and in vivo. J. Health Sci., 49, 123-128.
226. Yamaguchi, M., Hachiya, S., Hiratsuka, S. & Suzuki T. (2001). Effect of marine algae extract on bone calcification in the femoral-metaphyseal tissues of rats:Anabolic effect of Sargassum horneri. J. Health Sci., 47, 533-538.
227. Uchiyama, S. & Yamaguchi, M. (2002). Stimulatory effect of Sargassum horneri extract on bone formation in rat femoral-diaphyseal and-metaphyseal tissues in vitro. J. Health Sci., 48, 148-153.
228. Uchiyama, S. & Yamaguchi, M. (2002). Inhibitory effect of marine alga Sargassum horneri extract on bone resorption in tissue culture in vitro. J. Health Sci., 48, 154-160.
229. Uchiyama, S., Hashizume, M., Hokari, Y., Nakagawa, T., Igarashi, A. & Yamaguchi, M. (2004). Characterization of active component in marine alga Sargassum horneri extract in stimulating bone calcification in vitro. J. Health Sci., 50, 634-639.
230. Uchiyama, S. & Yamaguchi, M. (2002). Anabolic effect of marine alga Sargassum horneri extract on bone components in the femoral-diaphyseal and-metaphyseal tissues of young and aged rats in vivo. J. Health Sci., 48, 325-330.
231. Uchiyama, S. & Yamaguchi, M. (2003). Preventive effect of marine alga Sargassum horneri extract on bone loss in streptozotocin-diabetic rats in vivo. J Health Sci., 49, 149-155.
232. Matsumoto, T., Hokari, Y., Hashizume, M. & Yamaguchi, M.(2008). Effect of Sargassum horneri extract on circulating bone metabolic markers: Supplemental intake has an effect in health humans. J. Health Sci, 54, 50-55.
233. Yamaguchi, M., Hamamoto, R., Uchiyama, S., Ishiyama, K. & Hashimoto, K. (2006). Anabolic effects of bee pollen Cistus ladaniferus extract on bone components in the femoral-diaphyseal and-metaphyseal tissues of rats in vitro and in vivo. J. Health Sci.,52, 43-49.
234. Yamaguchi, M., Uchiyama, S. & Nakagawa, T. (2007). Anabolic effects of bee pollen Cistus ladaniferus extract in osteoblastic MC3T3-E1 cells in vitro. J. Health Sci., 53, 625-629.
235. Hamamoto, R., Ishiyama, K. & Yamaguchi, M. (2006). Inhibitory effects of bee pollen Cistus ladaniferus extract on bone resorption in femoral tissues and osteoclast-like cell formation in bone marrow cells in vitro. J. Health Sci., 52, 268-275.
236. Hidaka, S., Okamoto, Y., Uchiyama, S., Nakatsuma, A., Hashimoto, K., Ohnishi, S.T. & Yamaguchi, M. (2006). Royal Jelly prevents osteoporosis in rats: Beneficial effects in ovariectomy model and in bone tissue culture model. Based Complement. Alternat. Med., 3, 339-348.
237. Hamamoto, R., Ishiyama, K., Hashimoto, K. & Yamaguchi, M.(2006). Characterization of the active component in bee pollen Cistus ladaniferus extract in stimulating bone calcification and in inhibiting bone resorption in vitro. J. Health Sci., 52, 607-612.
238. Yamaguchi, M., Uchiyama, S. & Nakagawa, T. (2007). Preventive effects of bee pollen Cistus ladaniferus extract on bone loss in ovariectomized rats in vivo. J. Health Sci., 53, 571-575.
239. Yamaguchi, M., Hamamoto, R., Uchiyama, S., Ishiyama, K. & Hashimoto, K. (2007). Preventive effects of bee pollen Cistus ladaniferus extract on bone loss in streptozotocin-diabetic rats in vivo. J. Health Sci., 53, 190-195.